Table 4.

Effect size analyses and publication bias in studies of circulating FABP4, nesfatin-1, and OC levels in women with GDM

		Effect size analyses			Publication bias
Adipokines in GDM	N	SMD	95% CI	95% PI	Egger’s t	Egger’s P	Trim-and-fill SMD (95% CI)
FABP4	17	2.99	(2.28 to 3.69)	(0.28 to 5.71)	3.25	0.005	2.99 (2.28 to 3.69)
Nesfatin-1	7	−0.11	(−0.61 to 0.38)	(−1.63 to 1.41)	−1.27	0.24	−0.11 (− 0.61 to 0.38)
OC	7	0.68	(0.31 to 1.05)	(− 0.48 to 1.84)	1.87	0.09	0.68 (0.31 to 1.05)

N Number of studies, SMD Standardized mean difference, CI Confidence interval, PI Predictive interval